Literature DB >> 10933830

A recombinant lipoprotein antigen against Lyme disease expressed in E. coli: fermentor operating strategies for improved yield.

R D Madurawe1, T E Chase, E I Tsao, W E Bentley.   

Abstract

Decorin-binding lipoprotein, lpp-DBP, a bacterial surface adhesin, shows promise as a vaccine against Lyme disease. It is expressed in recombinant E. coli as an undesirable 20.5 KDa apoprotein that is subsequently lipidated in vivo to the desired 22 KDa lpp-DBP form. This study defines fermentation conditions for maximizing lpp-DBP yield. Super broth medium, a low post-induction temperature (30 degrees C), and a glucose feed based on dissolved oxygen resulted in high lpp-DBP yield and minimized apoprotein formation. Since cells lysed within 2-3 h after induction, the cell yield was maximized by growing cells to high cell density prior to induction. Compared to a glucose feed based on maintaining a constant fermentor glucose concentration (Glucose-Stat), feeding based on maintaining a constant dissolved oxygen level (DO-Stat) improved yields. Also, a dissolved oxygen level of 60% (air saturation) was best, as no product degradation was detected by Western blotting and SDS-PAGE. Acetic acid levels under both modes of glucose feed were sufficiently low, and no adverse growth effects were observed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933830     DOI: 10.1021/bp0000555

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  4 in total

1.  Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Authors:  Surianarayanan Bhuvanesh; Chakkaravarthi Arunkumar; Perumal Kaliraj; Subramanian Ramalingam
Journal:  J Ind Microbiol Biotechnol       Date:  2010-07-01       Impact factor: 3.346

2.  A recombinant vaccine against hydatidosis: production of the antigen in Escherichia coli.

Authors:  Daniel Manderson; Robert Dempster; Yusuf Chisti
Journal:  J Ind Microbiol Biotechnol       Date:  2005-09-30       Impact factor: 3.346

Review 3.  Recombinant protein expression in Escherichia coli: advances and challenges.

Authors:  Germán L Rosano; Eduardo A Ceccarelli
Journal:  Front Microbiol       Date:  2014-04-17       Impact factor: 5.640

4.  Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.

Authors:  Chen-Yi Chiang; Yi-Jyun Chen; Chiao-Chieh Wu; Shih-Jen Liu; Chih-Hsiang Leng; Hsin-Wei Chen
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.